Categories: Science

Crunching fruit fly and human data via machine learning and systems biology results in the identification of key metabolites that impact lifespan in both species


Discoveries that impact lifespan and healthspan in fruit flies are usually tested in mice before being considered potentially relevant in humans, a process that is expensive and time intensive. A pioneering approach taken at the Buck Institute leapfrogs over that standard methodology.

Utilizing cutting-edge machine learning and systems biology, researchers analyzed and correlated huge data sets from flies and humans to identify key metabolites that impact lifespan in both species.Results published online in Nature Communicationssuggest that one of the metabolites, threonine, may hold promise as a potential therapeutic for aging interventions.

“These results would not have been possible without this pioneering approach,” says Buck professor Pankaj Kapahi, PhD, senior author of the paper. “There is a lot of data sitting out there that is not being correlated between species. I think this approach could be a game-changer when it comes to identifying potential interventions to improve human health.”

Threonine has been shown to protect against diabetes in mice. The essential amino acid plays an important role in collagen and elastin production and is also involved in blood clotting, fat metabolism and immune function.

The method — simplified

The work began with former Buck postdoc Tyler Hilsabeck, PhD, crunching data (involving metabolomics, phenotypes and genomics) to analyze 120 metabolites in 160 strains of fruit flies on both restricted and normal diets. The goal was to reveal how different genotypes responded to the diets to influence lifespan and healthspan. “This allowed us to find the ‘needles in the haystack’ when it came to identifying relevant metabolites,” Hilsabeck says.

Vikram Narayan, PhD, a postdoctoral fellow then cross-referenced findings with human data from the massive UK Biobank. “Using the human data allowed us to focus on interesting metabolites to those that are conserved in both species. It also allowed us to uncover the impact of those metabolites in humans,” he says. Importantly, the team then brought those relevant metabolites back into the fly to validate results.

The results

In flies, threonine extended lifespan in a strain-and-sex-specific manner. Individuals with higher levels of threonine-related metabolites had longer, healthier lives. “We’re not saying that threonine is going to work in all conditions,” says Kapahi. “Our research shows it works in subsets of both flies and people. I think most of us have stopped expecting to find a ‘magic-bullet’ intervention for aging. Our method provides another way to develop precision medicine for geroscience.”

The results also include findings that were not so positive for both species. Orotate, which is relatively understudied and has been linked with fat metabolism, was negatively associated with aging. In flies orotate counteracted the positive impact of dietary restriction across every strain of the animals. In humans, orotate was linked to a shorter lifespan.

Larger implications

Kapahi hopes the larger research community will begin employing this method. “So many times we find things that work in worms and flies and then we don’t have the resources to move the basic science forward. This approach allows us to say with a lot more certainty that discoveries are going to be relevant in humans.” Kapahi says this method may reduce the need for studies in mice, something he welcomes.



Source link

24timenews.com

Recent Posts

Lowrider Stamps: On Sale Now!

The stamps are designed one-third wider than usual to show off as much detail in…

6 hours ago

Study finds ChatGPT gets science wrong more often than you think

Washington State University professor Mesut Cicek and his research team repeatedly tested ChatGPT by giving…

6 hours ago

Better Than Bronco And Defender In Water

Kia quotes a wading depth of 38.6 inches for the new Telluride X-Pro. The Land…

16 hours ago

Scientists finally reveal how this Alzheimer’s drug really works

Lecanemab, marketed as Leqembi, is a monoclonal antibody treatment for Alzheimer's disease that targets and…

16 hours ago

Atlys Secures $36 Million in Series C Funding with MakeMyTrip’s Investment, ETTravelWorld

Atlys has raised USD 36 million in a Series C funding round led by Susquehanna…

1 day ago

Porsche Is Developing A Gearbox That Switches Between Manual And Automatic

Porsche filed a new patent for a transmission gear selector that can operate an automatic…

1 day ago